Fantastic news for Moderna shareholders since they have failed clinical trials on every single other mRNA product they ever attempted to bring to market. Kind of hilarious though that the company that specializes in mRNA doesn't get the first FDA approval for an mRNA product too.
Fantastic news for Moderna shareholders since they have failed clinical trials on every single other mRNA product they ever attempted to bring to market. Kind of hilarious though that the company that specializes in mRNA doesn't get the first FDA approval for an mRNA product too.
FDA has been political way before these vaccines were submitted for approval. This approval is probably going to help speed up the approval process for other mRNA vaccines in the future.